Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_provenance.
- befree-2016 importedOn "2016-02-19" NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_provenance.
- NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_assertion wasGeneratedBy ECO_0000203 NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_provenance.
- NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_assertion wasDerivedFrom befree-2016 NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_provenance.
- NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_assertion SIO_000772 22052224 NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_provenance.
- NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_assertion evidence source_evidence_literature NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_provenance.
- NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_assertion description "[We evaluated seven single-nucleotide polymorphisms of six genes CDA Lys27Gln (A/C); CDA C435T; ERCC1 C118T; XRCC3 Thr241Met (C/T); XPD Lys751Gln (A/C); P53 Arg72Pro (G/C), and RRM1 C524T in 192 chemotherapy-naive patients with advanced NSCLC treated with cisplatin/gemcitabine-based regimen by TaqMan probe-based assays with 7300 Real-Time PCR System, using genomic DNA extracted from blood samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936057.RAcPU-zZrtKPK7SnA-qds3i_g9oSQnThblizm-L-t7elM130_provenance.